DeepScribe’s Post

We’re thrilled to announce our partnership with Integrated Oncology Network to deploy our generative AI technology for voice-automated medical notetaking, coding, and ordering into cCARE - California Cancer Associates for Research & Excellence's clinical operations to enhance oncology workflows and patient care experiences. "Oncology is a highly specialized and data-intensive field. This partnership will revolutionize how clinicians interact with medical records, enabling them to focus on what truly matters—the patient," said Dr. Jedidiah Monson, President of cCARE, the largest private oncology practice in California. "Through our strategic partnership with Knowtex, we are at the forefront of healthcare innovation, seamlessly integrating advanced AI into our workstreams," said Barry Tanner, CEO of Integrated Oncology Network. "This collaboration empowers our physicians to dedicate more valuable time directly with patients, affirming our commitment to innovation and leveraging cutting-edge technology to enhance patient care and outcomes." Read more here: https://lnkd.in/g_AxgsqR #Knowtex #generativeai #innovation #healthcare #doctors #oncology

It’s one of the greatest honors of my career to work with the team at AstraZeneca to use AI to make guideline-directed available to all patients. When my grandfather had lung cancer, life saving targeted therapies didn’t exist. Today, they do and it’s important that every patient can get access. One of the challenges of delivering Precision Medicine is the complexity and evolution of the best practice guidelines. Using AI technology to stay up-to-date with these advancements and to help ingest & structure the patient’s data in real-time makes it possible for all patients to be treated equitably. Tempus AI #healthequity American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) Annual Meeting is a premier gathering of #oncology professionals worldwide. Discover how our latest research sets the new standards in oncology, focusing on AI-driven diagnostics and personalized medicine. We have 3 abstracts accepted. One will be presented as a poster, and the others will be published online. 🧬 Prediction of oncogene mutation status in non-small cell lung cancer leveraging radiomics from CT scans: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods. 🧬 Unleashing deep features and radiomics to enhance best overall response prediction to immunotherapy in advanced non-small cell lung cancer    Please stop by our poster! Highlight Presentation by our VP of AI, Dr Ana Jimenez Pastor:  🧬 Overall survival prediction and risk stratification in patients with neuroblastoma through machine learning in the large multi-institutional PRIMAGE cohort. Our models provide superior risk stratification and survival predictions by leveraging a combination of clinical, molecular, and MR radiomics data.   We are excited to engage with the global oncology community to advance these technologies further. Find more about us here 👉 https://bit.ly/44J2sB5 #ASCO24

🔬 Announcement: AI in Precision Oncology Journal Launch! For those of you who've been tracking our journey, I'm thrilled to share a significant update. See video below and sign up if YOU would like us to mail you a copy of our preview issue. Over 1000 have signed up already! AI in Precision Oncology is more than just a scientific journal. Our team’s mission to fully realize the promise of AI in enhancing oncology care. It's about creating an AI-enabled health care system that's both equitable and patient-focused. Simply put, we're on a path to make health care feel more human. This journal will serve as a dedicated platform, highlighting the profound role of AI in oncology. As technological advancements in AI continue, there's a pressing need to bridge the gap between these innovations and their real-world clinical application. With AI in Precision Oncology, we hope to become that bridge, providing high-quality research, in-depth reviews, and relevant content to support our peers and the broader industry. I invite you to contribute and be a part of this important journey. We're currently welcoming manuscripts for our 2024 launch issue. Let's work together in this mission-driven initiative. For Authors: https://lnkd.in/g7Mzvf4r To sign up to receive your own copy, hit the link in the comments below and let me know what else you’d like to see us write about. Please help us spread the word: repost, share, tag friends with interest etc. we can use these tools to help save lives together. AI in Precision Oncology St. Elizabeth Healthcare St. Elizabeth Physicians

I just discovered an insightful publication in Cancer Medicine on the crucial role of communication in precision oncology between patients and healthcare professionals. It's a compelling dive into the challenges and best practices that can truly make a difference in patient care. It is highly recommended for anyone involved in healthcare to check it out and contribute to the ongoing discussion for better patient outcomes.   🔗 https://lnkd.in/dg5xtRKa #PrecisionOncology #PatientCare #HealthcareCommunication

Navigating the challenges in #oncology clinical trials require the collective effort of researchers, clinicians, policymakers, and patients alike. By harnessing the power of data, technology, and collaboration, we can overcome the challenges facing oncology #clinicaltrials and usher in a new era of personalized #cancercare. Read our full blog for more. Explore how IQA can boost your oncology trials: https://bit.ly/3R7FRbU #NationalCancerSurvivorsDay2024 #NCSD2024 #Blogs #ClinicalResearch #LifeSciences 

Recruiting for oncology trials can be difficult due to complex criteria, difficulty tracking disease progression, and trying to identify specific genetic profiles. We'll be at #ASCO24 discussing how Deep 6 AI helps solve for these issues with a comprehensive next-generation patient matching solution used by top NCI-designated cancer centers. Read the blog to learn more about how AI helps accelerate oncology clinical trial recruitment: https://lnkd.in/eNFzV2cP #oncologytrialrecruitment #clinicaltrials #cancertrials #clinicalresearch

📢🚫 Do you know that up to 50% of times your imaging assessments in clinical trials are done wrong? 🚫📢 We have measured 25% to 50% error rates when reviewing all imaging assessments on all active oncology trials at three National Cancer Institute (NCI)-designated Comprehensive Cancer Centers where we have performed the analysis. Curious what I mean? This article below is a must-read for all AACI (Association of American Cancer Institutes) who are leading the way in setting new standards. For those interested, send an email to info@yunu.io and ask to be included in our upcoming presentations and excerpts of the recorded panel that will be made available upon request. #Yunu, #ImagingClinicalTrials, #ClinicalTrials, #MedicalImaging, #Healthcare, #HealthTech, #CancerCenter, #Oncology, #Radiology, #AACI https://lnkd.in/etfSVnAC

"Equipping oncologists with the tools that reflect the depth of their field is not just about keeping pace – it’s about setting new standards of care," writes Sagran Moodley. As the oncology landscape continues to evolve, with updates to disease understanding, treatment methodologies, and biomarker research, using oncology-specific EHRs can help oncologists deliver the best possible care. Read more in this article on Answers Media Network. #EHR #Oncology #Biomarkers

Today I have the opportunity to share my experience matching patients to clinical trial using Deep 6 AI. I proudly built my first study and got pretty accurate matches without having to refine the initial build. #clinicalTrials #DiversityInClinicalTrials